12-Deoxyphorbol 13-acetate inhibits RANKL-induced osteoclastogenesis via the attenuation of MAPK signaling and NFATc1 activation.
Int Immunopharmacol
; 101(Pt A): 108177, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-34626872
Full text:
1
Database:
MEDLINE
Main subject:
Osteoporosis
/
Phorbol Esters
/
NFATC Transcription Factors
Type of study:
Prognostic_studies
Language:
En
Journal:
Int Immunopharmacol
Year:
2021
Type:
Article
Affiliation country:
China